Real-world effectiveness of early anti-SARS therapy in severely immunocompromised COVID-19 outpatients during the SARS-CoV-2 omicron variant era: a propensity score–adjusted retrospective cohort study
Early antiviral treatment was associated with a reduced risk of COVID-19-related hospitalization in ambulatory severely immunocompromised COVID-19 patients.
Authors
- Héctor Pinargote‐Celorio (ORCID: https://orcid.org/0000-0002-3300-5807)
- Esperanza Merino (ORCID: https://orcid.org/0000-0003-3854-4874)
- José Manuel Ramos (ORCID: https://orcid.org/0000-0002-6501-9867)
- Nicolás Merchante (ORCID: https://orcid.org/0000-0003-1120-8942)
- Pilar González-de-la-Aleja (ORCID: https://orcid.org/0000-0001-9360-7394)
- Belén Martínez-López (ORCID: https://orcid.org/0000-0002-8532-6864)
- Pedro María Martínez Pérez-Crespo (ORCID: https://orcid.org/0000-0003-2682-6655)
- Óscar Moreno (ORCID: https://orcid.org/0000-0002-8670-6404)
- Jara Llenas‐García (ORCID: https://orcid.org/0000-0001-9125-7706)
- Juan Carlos Rodrı́guez (ORCID: https://orcid.org/0000-0001-8007-5739)
Institutions
- Universitat de Miguel Hernández d'Elx (ES)
- Instituto de Salud Carlos III (ES)
- Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (ES)
- Centro de Investigación Biomédica en Red (ES)
- Instituto de Biomedicina de Sevilla (ES)
- Hospital General Universitario de Alicante Doctor Balmis (ES)
- Hospital Universitario de Valme (ES)
- Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL) (ES)
Publication Details
- Journal
- Journal of Antimicrobial Chemotherapy
- Published
- 2024-10-07
- DOI
- https://doi.org/10.1093/jac/dkae351
- Citations
- 3
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.17